Evidence map›Paper›PMID 42161537›Full record

ArticleBMJ open2026

Long-term effect of transcranial magnetic stimulation and transcranial electrical stimulation in primary progressive aphasia: study protocol for a randomised, double-blind clinical trial (RECONNECT-PLUS).

Lucía Fernández-Romero, María Díez-Cirarda, Cristina Delgado-Alonso, Maria Nieves Cabrera-Martin, Javier J González-Rosa, Carmen Sanz-Nieto, Natalia Pérez-Macías, Paloma Balugo, Natividad Gómez-Ruiz, Jorge Matias-Guiu and 2 more

Registry-linked trialAbstract readClinical Trial Protocol
In one paragraph

Article in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07158216 (Long-term Effect of Transcranial Magnetic Stimulation and Transcranial Electrical Stimulation in Primary Progressive Aphasia), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07158216 narecruitingnot on this map

Long-term Effect of Transcranial Magnetic Stimulation and Transcranial Electrical Stimulation in Primary Progressive Aphasia: Randomized, Double-blind Clinical Trial (RECONNECT-PLUS)

TypeinterventionalSponsorHospital San Carlos, MadridRan2025 to 2028Enrolled80ConditionsPrimary Progressive Aphasia(PPA)ArmsTMS, tDCS, Sham TMS, Sham tDCS
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Lucía Fernández-RomeroDepartment of Neurology, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Universidad Complutense de Madrid, Hospital Clinico San Carlos, Madrid, Spain lucia_28028@hotmail.com.ORCID http://orcid.org/0000-0003-0701-6227
María Díez-CirardaDepartment of Neurology, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Universidad Complutense de Madrid, Hospital Clinico San Carlos, Madrid, Spain.
Cristina Delgado-AlonsoDepartment of Neurology, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Universidad Complutense de Madrid, Hospital Clinico San Carlos, Madrid, Spain.
Maria Nieves Cabrera-MartinDepartment of Nuclear Medicine, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Universidad Complutense de Madrid, Hospital Clinico San Carlos, Madrid, Spain.
Javier J González-RosaInstitute of Research and Biomedical Innovation of Cadiz (INiBICA), University of Cadiz, Cádiz, Spain.
Carmen Sanz-NietoInstituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Unidad de Investigación Clínica y Ensayos Clínicos (UICEC), Madrid, Spain.
Natalia Pérez-MacíasInstituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Unidad de Investigación Clínica y Ensayos Clínicos (UICEC), Madrid, Spain.
Paloma BalugoDepartment of Clinical Neurophysiology, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Hospital Clinico San Carlos, Madrid, Spain.
Natividad Gómez-RuizDepartment of Radiology, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Universidad Complutense de Madrid, Madrid, Spain.
Jorge Matias-GuiuDepartment of Neurology, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Universidad Complutense de Madrid, Hospital Clinico San Carlos, Madrid, Spain.ORCID http://orcid.org/0000-0001-8162-9043
Antonio Portolés-PérezInstituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Unidad de Investigación Clínica y Ensayos Clínicos (UICEC), Madrid, Spain.ORCID http://orcid.org/0000-0002-5646-5275
Jordi A Matias-GuiuDepartment of Neurology, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Universidad Complutense de Madrid, Hospital Clinico San Carlos, Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPrimary progressive aphasia (PPA) is a neurodegenerative syndrome associated with Alzheimer's disease and frontotemporal degeneration. Non-invasive brain stimulation (NIBS) is a promising treatment, especially associated with language therapy, but comparative efficacy and long-term effects between the different techniques (transcranial direct current stimulation (tDCS) and transcranial magnetic stimulation (TMS)) remain unknown. The present study aims to investigate the effects of non-invasive brain stimulation, alone or associated (tDCS/TMS/tDCS plus TMS) combined with language therapy delivered during a period of 6 months, in the progression of language impairment in PPA, compared with sham stimulation combined with language therapy. METHODS AND ANALYSIS: The study is a randomised, double-blinded, parallel, sham-controlled clinical trial. Patients with PPA in early stages (global Clinical Dementia Rating equal to or less than 1) are eligible. They are to be randomised to one of the four treatment arms of the study (active tDCS-active TMS, active tDCS-sham TMS, sham tDCS-active TMS, sham tDCS-sham TMS). All patients will receive language therapy immediately after each session of NIBS, for 6 months. The primary outcome is the Mini-Linguistic State Examination. The secondary outcomes are naming of trained items, Addenbrooke's Cognitive Examination, Interview for Deterioration in Daily Living Activities, Clinical Dementia Rating including behaviour and language domains, Neuropsychiatric Inventory and regional brain metabolism. Exploratory substudies will be conducted including blood biomarkers, quantitative electroencephalography and spontaneous speech assessment. ETHICS AND DISSEMINATION: The study is registered (ClinicalTrials.gov: NCT07158216) and approved by the Ethics Committee of the Hospital Clinico San Carlos (code 25/309-IC_P_CE). Patients will be enrolled after signing an informed consent form. Study outcomes will be disseminated through presentations at scientific conferences, publications in peer-reviewed journals and other academic forums. TRIAL REGISTRATION NUMBER: NCT07158216.

Indexed as

Aphasia, Primary ProgressiveLanguage TherapyTranscranial Direct Current StimulationTranscranial Magnetic StimulationAgedDouble-Blind MethodFemaleHumansMaleMiddle AgedRandomized Controlled Trials as TopicTreatment OutcomeAgingBrainClinical TrialCognitionDementia

Identifiers

PMID42161537
PMCPMC13202099

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.